Literature DB >> 19501617

Mechanosensitive TRP channels in cardiovascular pathophysiology.

Ryuji Inoue1, Zhong Jian, Yasuhiro Kawarabayashi.   

Abstract

Transient receptor potential (TRP) proteins constitute a large non-voltage-gated cation channel superfamily, activated polymodally by various physicochemical stimuli, and are implicated in a variety of cellular functions. Known activators for TRP include not only chemical stimuli such as receptor stimulation, increased acidity and pungent/cooling agents, but temperature change and various forms of mechanical stimuli such as osmotic stress, membrane stretch, and shear force. Recent investigations have revealed that at least ten mammalian TRPs exhibit mechanosensitivity (TRPC1, 5, 6; TRPV1, 2, 4; TRPM3, 7; TRPA1; TRPP2), but the mechanisms underlying it appear considerably divergent and complex. The proposed mechanisms are associated with lipid bilayer mechanics, specialized force-transducing structures, biochemical reactions, membrane trafficking and transcriptional regulation. Many of mechanosensitive (MS)-TRP channel likely undergo multiple regulations via these mechanisms. In the cardiovascular system in which hemodynamic forces constantly operate, the impact of mechanical stress may be particularly significant. Extensive morphological and functional studies have indicated that several MS-TRP channels are expressed in cardiac muscle, vascular smooth muscle, endothelium and vasosensory neurons, each differentially contributing to cardiovascular (CV) functions. To further complexity, the recent evidence suggests that mechanical stress may synergize with neurohormonal mechanisms thereby amplifying otherwise marginal responses. Furthermore, the currently available data suggest that MS-TRP channels may be involved in CV pathophysiology such as cardiac arrhythmia, cardiac hypertrophy/myopathy, hypertension and aneurysms. This review will overview currently known mechanisms for mechanical activation/modulation of TRPs and possible connections of MS-TRP channels to CV disorders.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19501617     DOI: 10.1016/j.pharmthera.2009.05.009

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  62 in total

Review 1.  Piezo channels and GsMTx4: Two milestones in our understanding of excitatory mechanosensitive channels and their role in pathology.

Authors:  Thomas M Suchyna
Journal:  Prog Biophys Mol Biol       Date:  2017-08-06       Impact factor: 3.667

2.  Transient receptor potential vanilloid-1 (TRPV1) is a mediator of lung toxicity for coal fly ash particulate material.

Authors:  Cassandra E Deering-Rice; Mark E Johansen; Jessica K Roberts; Karen C Thomas; Erin G Romero; Jeewoo Lee; Garold S Yost; John M Veranth; Christopher A Reilly
Journal:  Mol Pharmacol       Date:  2011-12-09       Impact factor: 4.436

Review 3.  Pharmacology of transient receptor potential melastatin channels in the vasculature.

Authors:  Alexander Zholos
Journal:  Br J Pharmacol       Date:  2010-03-05       Impact factor: 8.739

Review 4.  Emerging concepts for the role of TRP channels in the cardiovascular system.

Authors:  Rudi Vennekens
Journal:  J Physiol       Date:  2010-12-20       Impact factor: 5.182

5.  Myristoylated alanine-rich C kinase substrate coordinates native TRPC1 channel activation by phosphatidylinositol 4,5-bisphosphate and protein kinase C in vascular smooth muscle.

Authors:  Jian Shi; Lutz Birnbaumer; William A Large; Anthony P Albert
Journal:  FASEB J       Date:  2013-09-10       Impact factor: 5.191

6.  G protein-coupled receptor signalling potentiates the osmo-mechanical activation of TRPC5 channels.

Authors:  Imane Jemal; Sergi Soriano; Anna Lucia Conte; Cruz Morenilla; Ana Gomis
Journal:  Pflugers Arch       Date:  2013-11-01       Impact factor: 3.657

7.  Expression of transient receptor potential channels and two-pore potassium channels in subtypes of vagal afferent neurons in rat.

Authors:  Huan Zhao; Leslie K Sprunger; Steven M Simasko
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-12-03       Impact factor: 4.052

8.  Could early ischemic arrhythmia triggered by purinergic activation of the transient receptor potential channels be prevented by creatine?

Authors:  Guy Vassort; Patrice Bideaux; Julio Alvarez
Journal:  Exp Clin Cardiol       Date:  2010

9.  Piezo1 incorporates mechanical force signals into the genetic program that governs lymphatic valve development and maintenance.

Authors:  Dongwon Choi; Eunkyung Park; Eunson Jung; Boksik Cha; Somin Lee; James Yu; Paul M Kim; Sunju Lee; Yeo Jin Hong; Chester J Koh; Chang-Won Cho; Yifan Wu; Noo Li Jeon; Alex K Wong; Laura Shin; S Ram Kumar; Ivan Bermejo-Moreno; R Sathish Srinivasan; Il-Taeg Cho; Young-Kwon Hong
Journal:  JCI Insight       Date:  2019-03-07

10.  Successful TRPV1 antagonist treatment for cardiac hypertrophy and heart failure in mice.

Authors:  Jaime S Horton; Cadie L Buckley; Alexander J Stokes
Journal:  Channels (Austin)       Date:  2012-12-06       Impact factor: 2.581

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.